| Literature DB >> 30816059 |
Sarah C Vos1, Jeannette Sutton2, C Ben Gibson3, Carter T Butts3.
Abstract
Social media platforms have the potential to facilitate the dissemination of cancer prevention and control messages following celebrity cancer diagnoses. However, cancer communicators have yet to systematically leverage these naturally occurring interventions on social media as these events are difficult to identify as they are unfolding and little research has analyzed their effect on social media conversations. In this study, we add to the research by analyzing how a celebrity cancer announcement influenced Twitter conversations in terms of the volume of social media messages and the type of content. Over a 9-day period, during which actor Ben Stiller announced that he had been treated for prostate cancer, we collected 1.2 million Twitter messages about cancer. We conducted automated content analyses to identify how often common cancer sites (prostate, breast, colon, or lung) were discussed. Then, we used manual content analysis on a sample of messages to identify cancer continuum content (awareness, prevention, early detection, diagnosis, treatment, survivorship, and end of life). Chi-square analyses were implemented to evaluate changes in cancer site and cancer continuum content before and after the announcement. We found that messages related to prostate cancer increased significantly more than expected for 2 days following Stiller's announcement. However, the number of cancer messages that described other cancer locations either did not increase or did not increase by the same magnitude. In terms of message content, results showed larger than expected increases in diagnosis messages. These results suggest opportunities to shape social media conversations following celebrity cancer announcements and increase prevention and early detection messages.Entities:
Keywords: cancer prevention; celebrity cancer announcements; content analysis; prostate cancer; twitter
Mesh:
Year: 2019 PMID: 30816059 PMCID: PMC6396054 DOI: 10.1177/1073274819825826
Source DB: PubMed Journal: Cancer Control ISSN: 1073-2748 Impact factor: 3.302
Tweet Content: Definitions, Descriptive Information, Intercoder Reliability, and Examples.
| Variable | Definition | Descriptive Information (n, % of Total) | Intercoder Reliabilitya | Example Tweetsb |
|---|---|---|---|---|
| Awareness | Fundraising, cancer prevalence, colors (pink), general research. | 636, 38.4% | α = 0.84 | RT @name: WEAR YELLOW TO TOMORROW’S HOME FOOTBALL GAME IN SUPPORT OF CHILDHOOD CANCER |
| Risk and prevention | Risk factors (eg, smoking), prevention behaviors, research. | 130, 6.5% | α = 0.92 | Fruit and veg! #prevent #cancer! @name @name @name |
| Early detection | Symptoms, signs, tests (eg, PSA test), research. | 278, 16.8% | α = 0.91 | RT @name Early Signs Of The Silent Killer Ovarian Cancer… |
| Diagnosis | Personal experience and research. | 82, 5.0% | α = 0.75 | RT @name: When your child has cancer, you go into survival mode. A mom reflects on her child’s #pediatriccancer diagnosis |
| Treatment | People in/remembering treatment and research. | 382, 23.1% | α = 0.82 | Praying for my grandma to have a successful surgery for her breast cancer tomorrow |
| Survivorship | Messages about life after treatment, includes research. | 100, 6.0% | α = 0.85 | Today, on the way home from finding out that my cancer is still in remission I almost pulled out in front of a speeding fire truck. Typical. |
| End of life | Information, experiences, and research related to death. | 73, 4.4% | α = 1 | Rest In Peace, abuelita Licha. Breast cancer took u from us way too soon, I’ll forever have u looking over us. ud83dudc97u2026 |
Abbreviation: PSA, prostate-specific antigen.
a Intercoder reliability was measured using Krippendorff α.[20]
b Account names have been anonymized.
Figure 1.The volume of Twitter messages containing keywords related to prostate cancer or actor Ben Stiller over the course of the study period (September 30 to October 8, 2016). Notice the sharp increase in messages on October 4 and 5, following Stiller’s announcement.
Figure 2.The total volume of cancer-related Twitter messages collected each day during the study period.
Figure 3.The volume of messages containing keywords related to breast, colorectal, and lung cancer during the study period. Notice the sharp increase in breast cancer messages beginning on October 1, the first day of Breast Cancer Awareness Month.
Chi-Square Analyses Examining Volume of Messages Before and After Stiller’s Announcement.a
| χ2 ( |
| Before (October 2 and 3) | After (October 4 and 5) | Total | |
|---|---|---|---|---|---|
| Total tweets | – | 252 873 | 292 682 | 525 555 | |
| Cancer site | n (% of time period) | ||||
| Prostate | 13 089.28 (1) | .00 | 3170 (1.3%) | 23 150 (7.9%) | 26 320 |
| Standardized residual | −81.8 | 76 | |||
| Breast | 2056.06 (1) | .00 | 72 536 (28.7%) | 68 191 (23.3%) | 140 727 |
| Standardized residual | 28.6 | −26.6 | |||
| Colorectum | 10.50 (1) | .00 | 1249 (0.5%) | 1271 (0.4%) | 2520 |
| Standardized residual | 2.4 | −2.2 | |||
| Lung | 218.00 (1) | .00 | 3821 (1.5%) | 5981 (2.0%) | 9802 |
| Standardized residual | −10.7 | 10.0 | |||
a In order to control for type I error, the significance value for this set of analyses was set at 0.05 and divided among the tests. As a result, the test-level significance value was P < .02.
Chi-Square Analyses Examining Cancer Continuum Content Before and After Stiller’s Announcement.a
| χ[ |
| Before (October 2 and 3) | After (October 4 and 5) | Total | |
|---|---|---|---|---|---|
| Total tweets | − | 346 | 438 | 784 | |
| Cancer continuum content | n, (% of time period) | ||||
| Awareness | 12.57 (1) | .00 | 160 (46.2%) | 148 (33.8%) | 308 |
| Standardized residual | 2.1 | −1.8 | |||
| Risk and prevention | 0.11 (1) | .74 | 34 (9.8%) | 40 (9.1%) | 74 |
| Standardized residual | 0.2 | −0.2 | |||
| Early detection | 0.12 (1) | .73 | 53 (15.3%) | 71 (16.2%) | 124 |
| Standardized residual | −0.2 | 0.2 | |||
| Diagnosis | 10.59 (1) | .00 | 10 (2.9%) | 37 (8.4%) | 47 |
| Standardized residual | −2.4 | 2.1 | |||
| Treatment | 8.17 (1) | .00 | 55 (15.9%) | 106 (24.2%) | 161 |
| Standardized residual | −1.9 | 1.7 | |||
| Survivorship | 2.55 (1) | .11 | 19 (5.5%) | 37 (8.4%) | 56 |
| Standardized residual | −1.1 | 1.0 | |||
| End of life | 0.01 (1) | .94 | 17 (4.9%) | 21 (4.8%) | 38 |
| Standardized residual | 0.1 | 0.0 | |||
a In order to control for type I error, the significance value for this set of analyses was set at P <.05 and divided among the tests. As a result, the test-level significance value was P < .01.